0001615219 2026-06-11 2026-06-11 0001615219 1 2026-06-11 2026-06-11 iso4217:USD pure shares S-1 S-1 EX-FILING FEES 0001615219 Decoy Therapeutics Inc. N/A N/A S-1 Decoy Therapeutics Inc. false Equity Common Stock, par value $0.0001 per share true 808000 6.07 4904560.00 0.0001381 677.32 4904560.00 677.32 0.00 0.00 677.32 (1) Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the "Securities Act"), this Registration Statement shall also cover an indeterminate number of additional shares of common stock, par value $0.0001 per share ("Common Stock"), of Decoy Therapeutics Inc. (the "Registrant") as may be issued or issuable resulting from stock splits, stock dividends or similar transactions. (2) Includes (i) up to 800,000 shares of Common Stock that are issuable pursuant to a securities purchase agreement, dated December 12, 2024, as amended (the "Purchase Agreement"), by and between the Registrant and C/M Capital Master Fund, LP ("Capital Master"), as Purchase Shares, and (ii) up to 8,000 shares of Common Stock that are issuable to Capital Master as consideration for Capital Master's execution and delivery of the Purchase Agreement, as Commitment Shares. The Registrant will not receive any proceeds from the resale of such shares by the selling stockholder. (3) Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) of the Securities Act, based on the average of the high and low prices for a share of the Registrant's Common Stock as reported on the Nasdaq Stock Market, LLC on June 8, 2026, which is a date within five business days of the filing of the Registration Statement.